Photodynamic therapy: Extended indication;Photodynamische therapie: Erweiterte indikationen

Ophthalmologe

Volumn 100, Issue 5, 2003, Pages 384-390

  Muller Velten R ^a   Michels, St ^a   Schmidt Erfurth, U ^a   Laqua, H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Choroidal neovascularization; CNV; Extended indication; PDT; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; RETINA FLUORESCEIN ANGIOGRAPHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY;

CHOROIDAL NEOVASCULARIZATION; EPIRETINAL MEMBRANE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0037600403     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-002-0723-9     Document Type: Article

References (15)

1. Gal D, MacDonald P, Porter J, Simpson E (1981) Cholesterol metabolism in cancer cells in monolayer culture. Int J Cancer 28:315-319
2. Macular Photocaogulation Study Group (1994) Laser photocoagulation for juxtafoveal choroidal neovascularisation: five-year results from randomised clinical trials. Arch Ophthalmol 112:500-509
3. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte T, Birngruber R (1994) Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101:1953-1961
4. Schmidt-Erfurth U, Hasan T, Schomacker K et al. (1995) In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med 17:178-188
5. Schmidt-Erfurth U, Hasan T (2000) Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 45:195-213
6. Sickenberg M, Schmidt-Erfurth U, Miller J, Purnaras C et al. (2000) A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularisation in pathologic myopia, ocular histoplasmosis syndrom, angioid streaks and idiopathic causes. Arch Ophthalmol 117:327-336
7. Treatment of age-related maculardegeneration with photodynamic therapy (TAP) study group (1999) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. Arch Ophthalmol 117:1329-1345
8. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: two year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119:198-207
9. Verteporfin in photodynamic therapy (VIP) study group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in pathologic myopia with Verteporfin. One-year results of a randomised clinical trial - VIP report No.1. Ophthalmology 108:841-852
10. Virgili G et al. (2002) Photodynamic therapy of choroidal neovascularization associated with angioid streaks. ARVO 592
11. Shaikh S et al. (2002) Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. ARVO 571
12. Huang S J et al. (2002) Photodynamic therapy for extrafoveal and juxtafoveal choroidal neovascularization. ARVO 581
13. Verteporfin roundtable 2000 and 2001 participants (2002) Guidelines for using verteporfin (Visudyne) to treat choroidal neovascularization due to age related macular degeneration and other causes. Retina 22 (1):6-18
14. Saperstein D et al. (2002) Effects of verteporfin therapy on choroidal neovascularization secondary to the ocular histoplasmosis syndrome (VOH Study). ARVO 982
15. Potter MJ, Szabo SM, Chan EYY, Morris AH (2001) Photodynamic therapy for choroidal neovascularization in type 2A idiopathic juxtafovealar retinal teleangiectasis. IOVS 42 (4)